Tu Noah P, Searle Philip A, Sarris Kathy
Discovery Chemistry & Technology, AbbVie, Inc., North Chicago, IL USA
Discovery Chemistry & Technology, AbbVie, Inc., North Chicago, IL USA.
J Lab Autom. 2016 Jun;21(3):459-69. doi: 10.1177/2211068215590580. Epub 2015 Jun 17.
A novel methodology for the synthesis and purification of drug-like compound libraries has been developed through the use of a microwave reactor with an integrated high-performance liquid chromatography-mass spectrometry (HPLC-MS) system. The strategy uses a fully automated synthesizer with a microwave as energy source and robotic components for weighing and dispensing of solid reagents, handling liquid reagents, capper/crimper of microwave reaction tube assemblies, and transportation. Crude reaction products were filtered through solid-phase extraction cartridges and injected directly onto a reverse-phase chromatography column via an injection valve. For multistep synthesis, crude products were passed through scavenger resins and reintroduced for subsequent reactions. All synthetic and purification steps were conducted under full automation with no handling or isolation of intermediates, to afford the desired purified products. This approach opens the way to highly efficient generation of drug-like compounds as part of a lead discovery strategy or within a lead optimization program.
通过使用配备集成高效液相色谱 - 质谱(HPLC - MS)系统的微波反应器,已开发出一种用于合成和纯化类药物化合物库的新方法。该策略使用全自动合成仪,以微波作为能源,并配备机器人组件用于称量和分配固体试剂、处理液体试剂、密封/卷曲微波反应管组件以及运输。粗反应产物通过固相萃取柱过滤,并通过进样阀直接注入反相色谱柱。对于多步合成,粗产物通过清除树脂,然后重新引入进行后续反应。所有合成和纯化步骤均在完全自动化的条件下进行,无需处理或分离中间体,从而得到所需的纯化产物。这种方法为作为先导化合物发现策略的一部分或在先导化合物优化计划中高效生成类药物化合物开辟了道路。